- China eyes a bull market?
- The top health care ETFs for the week.
- Tracking ETF fund flows.
Monday, July 13, 2020 – Although investors might have expected a pause in the stock market last week with continuing COVID-19 concerns, the bull market rages on. Stocks jumped at the start of trading this past Monday, with many accrediting the bump to a front-page editorial in the China Securities Journal, which stated that “fostering a healthy bull market after the pandemic is now more important to the economy than ever.” When a state-run publication appears to endorse a rally in equities, people listen and by Friday, the large-cap CSI 300 Index and Shanghai Composite Index rallied 7.5% and 7.3%, respectively.
In the US, all major indices ended the week on a positive note as well, with the Dow Jones Industrial Average advancing 1.44%, the S&P 500 rose 1.05% and Nasdaq gained 0.66%. Small-Caps outperformed with the Russell 2000 adding 1.70%. Looking at the sector break down, 9 of the 11 closed higher. Financials led the pack gaining 3.44% and Health Care lagged with -0.24%.
U.S. listed ETPs saw approximately $7 billion of inflow which seems like a relatively quiet week these days. The biggest winners on the top five list were Invesco QQQ Trust (QQQ), iShares iBoxx USD Investment Grade Corporate Bond ETF (LQD), iShares Core U.S. Aggregate Bond ETF (AGG), SPDR Bloomberg Barclays High Yield Bond ETF (JNK) and iShares 20+ Year Treasury Bond ETF (TLT). Invesco QQQ Trust (QQQ) saw a $2.2 billion inflow while the remaining ETFs brought in approximately $1.2 billion, $815 million, $650 million and $620 million respectively. For outflows, the iShares Russell 2000 ETF (IWM) led shedding $1.9 billion in AUM and SPDR S&P 500 ETF Trust (SPY) saw around $1.5 billion in redemptions.
Looking ahead, the second quarter earnings season kicks off on Monday, with 8% of the S&P 500 constituents reporting earnings this week. In addition, important economic data being released includes Consumer Price Index (CPI) on Tuesday, retail sales on Thursday, and housing statistics begin on Friday.
ETFG Quant Movers - Those ETFs who have had the largest weekly change in their respective, overall ETFG Quant ratings.
ETFG Quant Winners: The top five gainers in their ETFG Quant Total Score were iPath S&P MLP ETN (IMLP), Innovator IBD ETF Leaders ETF (LDRS), Franklin FTSE Europe Hedged ETF (FLEH), Global X MSCI Super Dividend Emerging Markets ETF (SDEM), and AdvisorShares Vice ETF (ACT). Each ETP added approximately 10% to their overall ETFG Quant Total Score.
ETFG Quant Losers: Honorable mentions in the loser category were ELEMENTS SPECTRUM ETN (EEH), First Trust Preferred Securities and Income ETF (FPE), Schwab Fundamental Emerging Markets Large Company Index ETF (FNDE), iShares MSCI Finland ETF (EFNL) and SPDR Solactive Germany ETF (ZDEU). Each ETF lost around 15% in Quant Total Score and the reasons for the drop can be traced to mostly behavioral factors.
ETFG Weekly Select List - The five most highly rated ETFs per Sector, Geographic Region and Strategy as ranked by the ETFG Quant model.
Considering the sector’s potential bounce back from this week’s lack luster performance, we’d like to highlight the top ETFs within the Health Care sector in this week’s Select List. SPDR S&P Biotech ETF (XBI) held on the 1st place while iShares Nasdaq Biotechnology ETF (IBB) moved from 5th to claim the 2nd spot this week. John Hancock Multifactor Healthcare ETF (JHMH) held on the 3rd place and KraneShares Emerging Markets Healthcare Index ETF (KMED) Fidelity MSCI Health Care Index ETF (FHLC) the two newcomers to this week’s Select List claimed 4th and 5th respectively.
Thank you for reading the ETF Global Perspectives!
ETFG 21 Day Free Trial: Sign Up
Assumptions, opinions and estimates constitute our judgment as of the date of this material and are subject to change without notice. ETF Global LLC (“ETFG”) and its affiliates and any third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively ETFG Parties) do not guarantee the accuracy, completeness, adequacy or timeliness of any information, including ratings and rankings and are not responsible for errors and omissions or for the results obtained from the use of such information and ETFG Parties shall have no liability for any errors, omissions, or interruptions therein, regardless of the cause, or for the results obtained from the use of such information. ETFG PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE.
In no event shall ETFG Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of the information contained in this document even if advised of the possibility of such damages.
ETFG ratings and rankings are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold, or sell any securities or to make any investment decisions. ETFG ratings and rankings should not be relied on when making any investment or other business decision. ETFG’s opinions and analyses do not address the suitability of any security. ETFG does not act as a fiduciary or an investment advisor. While ETFG has obtained information from sources they believe to be reliable, ETFG does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives.
This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities, financial instruments or strategies mentioned herein may not be suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only correct as of the stated date of their issue. Prices, values, or income from any securities or investments mentioned in this report may fall against the interests of the investor and the investor may get back less than the amount invested. Where an investment is described as being likely to yield income, please note that the amount of income that the investor will receive from such an investment may fluctuate. Where an investment or security is denominated in a different currency to the investor's currency of reference, changes in rates of exchange may have an adverse effect on the value, price or income.
Analyst's Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.